Search
Close this search box.

Publications from the ReMuS registry data

Since its inception, the ReMuS registry has produced many scientific publications. The results of the ReMuS registry have been presented at national and international conferences and the information from the registry is thus available to experts at the annual Czech and Slovak Neurological Congress, the Jedlička Neuroimmunological and Liquorological Days symposium and many other professional meetings. The results of the annual data collection are traditionally published on the occasion of the World Multiple Sclerosis Day at the spring press conference in Prague.

For more information, please refer directly to the section About us.

#20A2DC

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe

26 September 2023

Nicholas, R., Rodgers, J., Witts, J., Lerede, A., Friede, T., Hillert, J., Forsberg, L., Glaser, A., Manouchehrinia, A., Ramanujam, R., Spelman, T., Klyve, P., Drahota, J., Horakova, D., Joensen, H., Pontieri, L., Magyari, M., Ellenberger, D., Stahmann, A., Butzkueven, H.,  Van Der Walt, A., Bezlyak, V., Lines C., Middleton, R. (2023). The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe. Therapeutic advances in neurological disorders, 16, 17562864231198963. https://doi.org/10.1177/17562864231198963 PMID: 37771841

#20A2DC

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries.

12 June 2023

Hrnciarova, T., Drahota, J., Spelman, T., Hillert, J., Lycke, J., Kubala Havrdova, E., Recmanova, E., Adamkova, J., Mares, J., Libertinova, J., Pavelek, Z., Hradilek, P., Ampapa, R., Stetkarova, I., Peterka, M., Martinkova, A., Stourac, P., Grunermelova, M., Vachova, M. Horakova, D. (2023). Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries. In Multiple Sclerosis and Related Disorders (Vol. 76, s. 104803). Elsevier BV. https://doi.org/10.1016/j.msard.2023.104803 PMID: 37329786

The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021

The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021

28 April 2023

Stastna, D., Drahota, J., Lauer, M., Mazouchova, A., Menkyova, I., Adamkova, J., Ampapa, R., Dufek, M., Grunermelova, M., Hradilek, P., Kubala Havrdova, E., Mares, J., Martinkova, A., Pavelek, Z., Peterka, M., Recmanova, E., Rockova, P., Stetkarova, I., Stourac, P. , Vachova, M., Horakova, D. (2023). The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021. In Biomedical Papers. Palacky University Olomouc. https://doi.org/10.5507/bp.2023.015 PMID: 37114703

Is breastfeeding in MS harmful or not? An answer from real-world Czech data

16 June 2023

Hradilek, P., Zapletalova, O., Hanulikova, P., Havrdova, E. K., Woznicova, I., Mazouchova, A., Drahota, J., Lauer, M., Stetkarova, I., Valis, M., Libertinova, J., Stourac, P., Adamkova, J., Ampapa, R., Vachova, M., Dufek, M., Martinková, A., Peterka, M., Recmanova, E., Mares, J. Horakova, D. (2023). Is breastfeeding in MS harmful or not? An answer from real-world Czech data. In Multiple Sclerosis and Related Disorders (Vol. 76, p. 104790). Elsevier BV. https://doi.org/10.1016/j.msard.2023.104790 PMID: 37348317

Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers

16 February 2023

Forsberg, L., Spelman, T., Klyve, P., Manouchehrinia, A., Ramanujam, R., Mouresan, E., Drahota, J., Horakova, D., Joensen, H., Pontieri, L., Magyari, M., Ellenberger, D., Stahmann, A., Rodgers, J., Witts, J., Middleton, R., Nicholas, R., Bezlyak, V., Adlard, N., Hach, T., Lines, C., Vukusic, S., Soilu-Hänninen, M., van der Walt, A., Butzkueven, H., Iaffldano, P., Trojano, M., Glaser, A., Hillert, J., SPMS Research Collaboration Network (2023). Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers. In Multiple Sclerosis Journal – Experimental, Translational and Clinical (Vol. 9, Issue 1, p. 205521732311535). SAGE Publications. https://doi.org/10.1177/20552173231153557 PMID: 36816812

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection

2 July 2022

Stastna, D., Menkyova, I., Drahota, J., Hrnciarova, T., Kubala Havrdova, E., Vachova, M., Andelova, M., Kleinova, P., Kovarova, I., Krasulova, E., Preiningerova, J. L., Novakova, I., Novotna, K., Novotna, M., Nytrova, P., Pavlickova, J., Srpova, B., Storey, K., Ticha, V., Tyblova, M., Uher, T., Vodehnalova, K., Horakova, D. (2022). To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection. In Multiple Sclerosis and Related Disorders (Vol. 65, p. 104014). Elsevier BV. https://doi.org/10.1016/j.msard.2022.104014 PMID: 35803085

Abstract MS child

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry

18 April 2022

Vališ, M., Pavelek, Z., Novotný, M., Klímová, B., Šarláková, J., Halúsková, S., Peterka, M., Štětkárová, I., Štourač, P., Mareš, J., Hradílek, P., Ampapa, R., Vachová, M., Recmanová, E., & Meluzínová, E. (2022). Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry. In Frontiers in Neurology (Vol. 13). Frontiers Media SA. https://doi.org/10.3389/fneur.2022.851426 PMID: 35518208

Oral cladribine in the treatment of multiple sclerosis - data from the national ReMuS registry®

9 December 2021

Horáková, D., Vachová, M., Tvaroh, A., Drahota, J., Mazouchová, A., Mareš, J., Woznicová, I., Zimová, D., Libertínová, J., Martinková, A., Recmanová, E., Grunermelová, M., Vališ, M., Adámková, J., Ampapa, R., Benešová, Y., Dufek, M., Peterka, M., & Kubala Havrdová, E. (2021). Oral cladribine in the treatment of multiple sclerosis – data from the national registry ReMuS® registry. In Czech and Slovak Neurology and Neurosurgery (Vol. 84/117, Issue 6). Care Comm. https://doi.org/10.48095/cccsnn2021555

Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic

Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1,533 pregnancies in Czech Republic.

28 November 2021

Hradilek, P., Meluzinova, E., Zapletalova, O., Hanulikova, P., Horakova, D., Woznicova, I., Pavliska, L., Stetkarova, I., Valis, M., Stourac, P., Adamkova, J., Ampapa, R., Vachova, M., & Mares, J. (2022). Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic. In Multiple Sclerosis and Related Disorders (Vol. 59, p. 103391). Elsevier BV. https://doi.org/10.1016/j.msard.2021.103391 PMID: 35240415

Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia

24 June 2021

Stastna, D., Menkyova, I., Drahota, J., Mazouchova, A., Adamkova, J., Ampapa, R., Grunermelova, M., Peterka, M., Recmanova, E., Rockova, P., Rous, M., Stetkarova, I., Valis, M., Vachova, M., Woznicova, I., & Horakova, D. (2021). Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia. In Multiple Sclerosis and Related Disorders (Vol. 54, p. 103104). Elsevier BV. https://doi.org/10.1016/j.msard.2021.103104 PMID: 34216998

Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network

17 March 2021

Hillert, J., Magyari, M., Soelberg Sørensen, P., Butzkueven, H., Van Der Welt, A., Vukusic, S., Trojano, M., Iaffaldano, P., Pellegrini, F., Hyde, R., Stawiarz, L., Manouchehrinia, A., & Spelman, T. (2021). Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network. In Frontiers in Neurology (Vol. 12). Frontiers Media SA. https://doi.org/10.3389/fneur.2021.647811 PMID: 33815259

Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS

12 January 2021

Pavelek, Z., Sobíšek, L., Šarláková, J., Potužník, P., Peterka, M., Štětkárová, I., Štourač, P., Mareš, J., Hradílek, P., Ampapa, R., Grünermelová, M., Vachová, M., Recmanová, E., Angelucci, F., Halúsková, S., & Vališ, M. (2021). Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS. In Frontiers in Neurology (Vol. 11). Frontiers Media SA. https://doi.org/10.3389/fneur.2020.593527 PMID: 33510704

What data does the national registry of patients with multiple sclerosis ReMuS offer?

October 2020

doc. MUDr. Dana Horáková, Ph.D.

Neurologie pro praxi

Multiple Sclerosis Patient Registry ReMuS - the importance of data in chronic diseases

21 December 2019

doc. MUDr. Dana Horáková, Ph.D.

Remedia

Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS

3 August 2019

Horakova, D., Rockova, P., Jircikova, J., Dolezal, T., Vachova, M., Hradilek, P., Valis, M., Sucha, J., Martinkova, A., Ampapa, R., Grunermelova, M., Stetkarova, I., Stourac, P., Mares, J., Dufek, M., Kmetova, E., Adamkova, J., & Hrnciarova, T. (2019). Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS. In Multiple Sclerosis and Related Disorders (Vol. 35, pp. 196–202). Elsevier BV. https://doi.org/10.1016/j.msard.2019.08.003 PMID: 31400559

MSARD Glaser Anna 2019

Multiple sclerosis registries in Europe – An updated mapping survey

4 October 2018

Glaser, A., Stahmann, A., Meissner, T., Flachenecker, P., Horáková, D., Zaratin, P., Brichetto, G., Pugliatti, M., Rienhoff, O., Vukusic, S., de Giacomoni, A. C., Battaglia, M. A., Brola, W., Butzkueven, H., Casey, R., Drulovic, J., Eichstädt, K., Hellwig, K., Iaffaldano, P., Ioannidon, E., Kuhle, E., Lycke, K., Magyari, M., Malbaša, T., Middelton, R., Myhr, K. M., Notas, K., Orologas, A., Otero-Romero, S., Pekmezovic, T., Sastre-Garriga, J., Seeldrayers, P., Soilu-Hännien, M., Stawiarz, L., Trojano, M., Zeimssen, T., Hilletr, J., Thalheim, C. (2019). Multiple sclerosis registries in Europe – An updated mapping survey. In Multiple Sclerosis and Related Disorders (Vol. 27, pp. 171–178). Elsevier BV. https://doi.org/10.1016/j.msard.2018.09.032 PMID: 30384204

Registry of patients with multiple sclerosis ReMuS - What have we reached in five years of existence of the registry

10 December 2018

doc. MUDr. Dana Horáková, Ph.D.

Neurologie pro praxi

A comparison of efficacy of subcutaneous interferon β-1a 44 μg, dimethyl fumarate and fingolimod in the real-life clinical practise – a multicenter observational study

7 July 2018

Pavelek, Z., Sobíšek, L., & Vališ, M. (2017). A comparison of efficacy of subcutaneous interferon β-1a 44 μg, dimethyl fumarate and fingolimod in the real-life clinical practise – a multicenter observational study. In Czech and Slovak Neurology and Neurosurgery (Vol. 81/114, Issue 4, pp. 457–465). Care Comm. https://doi.org/10.14735/amcsnn2018457

ReMuS - The Czech Republic National Multiple Sclerosis Patient Registry

November 2016

doc. MUDr. Dana Horáková, Ph.D.
 
Multiple Sclerosis NEWS
Newsletter registru ReMuS

Příležitostně Vám budeme zasílat novinky z oblasti výzkumu roztroušené sklerózy a registru ReMuS formou digitálního newsletteru.